StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.21+0.05 (+1.20%)

Close on Nov 20, 2026Market cap $1.51BP/E –Yield –

Precigen free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Precigen's free cash flow for the twelve months ending Jun 30, 2026 was -$115.22M. For fiscal 2025 it was -$89.83M. The highest annual figure on record is $22.92M in fiscal 2015.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$89.83M–
FY2024Dec 31, 2024-$76.76M–
FY2023Dec 31, 2023-$68.47M–
FY2022Dec 31, 2022-$69.97M–
FY2021Dec 31, 2021-$63.02M–
FY2020Dec 31, 2020-$84.55M–
FY2019Dec 31, 2019-$173.81M–
FY2018Dec 31, 2018-$165.83M–
FY2017Dec 31, 2017-$150.39M–
FY2016Dec 31, 2016-$80.62M-451.7%
FY2015Dec 31, 2015$22.92M–
FY2014Dec 31, 2014-$26.23M–
FY2013Dec 31, 2013-$55.21M–
FY2012Dec 31, 2012-$69.02M–
FY2011Dec 31, 2011-$94.76M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$18.20M–
Q1 FY2026Mar 31, 2026-$44.09M–
Q4 FY2025Dec 31, 2025-$23.48M–
Q3 FY2025Sep 30, 2025-$29.46M–
Q2 FY2025Jun 30, 2025-$19.94M–
Q1 FY2025Mar 31, 2025-$16.95M–
Q4 FY2024Dec 31, 2024-$9.27M–
Q3 FY2024Sep 30, 2024-$23.62M–
Q2 FY2024Jun 30, 2024-$25.43M–
Q1 FY2024Mar 31, 2024-$18.44M–
Q4 FY2023Dec 31, 2023-$16.81M–
Q3 FY2023Sep 30, 2023-$17.24M–
Q2 FY2023Jun 30, 2023-$15.87M–
Q1 FY2023Mar 31, 2023-$18.54M–
Q4 FY2022Dec 31, 2022-$15.45M–
Q3 FY2022Sep 30, 2022-$25.39M–
Q2 FY2022Jun 30, 2022-$8.77M–
Q1 FY2022Mar 31, 2022-$20.36M–
Q4 FY2021Dec 31, 2021-$17.36M–
Q3 FY2021Sep 30, 2021-$19.29M–
Q2 FY2021Jun 30, 2021-$8.97M–
Q1 FY2021Mar 31, 2021-$17.40M–
Q4 FY2020Dec 31, 2020-$17.94M–
Q3 FY2020Sep 30, 2020-$20.03M–
Q2 FY2020Jun 30, 2020-$15.69M–
Q1 FY2020Mar 31, 2020-$30.90M–
Q4 FY2019Dec 31, 2019-$36.83M–
Q3 FY2019Sep 30, 2019-$34.92M–
Q2 FY2019Jun 30, 2019-$47.30M–
Q1 FY2019Mar 31, 2019-$54.76M–
Q4 FY2018Dec 31, 2018-$48.60M–
Q3 FY2018Sep 30, 2018-$37.59M–
Q2 FY2018Jun 30, 2018-$38.99M–
Q1 FY2018Mar 31, 2018-$40.66M–
Q4 FY2017Dec 31, 2017-$47.87M–
Q3 FY2017Sep 30, 2017-$36.42M–
Q2 FY2017Jun 30, 2017-$35.06M–
Q1 FY2017Mar 31, 2017-$31.03M–
Q4 FY2016Dec 31, 2016-$28.64M–
Q3 FY2016Sep 30, 2016-$25.89M–

More Precigen figures

See a number that looks wrong?